Martin H. Huber Jr. - May 19, 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Director
Signature
/s/ Michael A. Metzger, as Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
May 19, 2025
Transactions value $
$44,950
Form type
4
Date filed
5/19/2025, 04:02 PM
Previous filing
Feb 7, 2025
Next filing
Sep 15, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Huber Martin H. Jr. Director C/O SYNDAX PHARMACEUTICALS, INC., 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, as Attorney-in-Fact 2025-05-19 0001653276

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Purchase $45K +5K +6.76% $8.99 79K May 19, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.